Skip to main contentSkip to navigation
Sirius Investors

DGX Stock: Quest Diagnostics Incorporated Stock Price, Analysis & Insights

Get live dgx stock price $190.15, comprehensive Quest Diagnostics Incorporated stock analysis, charts, news, and expert forecast. Real-time dgx stock data and investment insights.

190.15
0.34%Today
DGXQuest Diagnostics Incorporated • New York Stock Exchange • Healthcare
Market Cap
21.26B
Volume
1.03M
52W High
191.87
52W Low
146.91
Upgrade to Pro or Premium to access long-term historical data (3M, 6M, 1Y, 2Y, 5Y, 10Y, Max)

Company Overview

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Company Information

CEO
James E. Davis
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
55000

Contact Information

Address
500 Plaza Drive
Country
US

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 21.26B market capitalization
  • Trading Volume: 1.03M shares traded today
  • Price Range: 52-week range of $146.91 - $191.87
  • Exchange: Listed on New York Stock Exchange

Financial Metrics

P/E Ratio:22.75
EPS:$8.36
Beta:0.56
Avg Volume:946.59K

Market Analysis for Quest Diagnostics Incorporated

Quest Diagnostics Incorporated (DGX) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 21.26B, the company represents a significant player in its market. The stock is currently trading at $190.15 with a positivedaily change of 0.34%.

The company's 55000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 22.75, beta of 0.56, and 52-week price range from $146.91 to $191.87when evaluating investment opportunities.

Why Invest in Quest Diagnostics Incorporated?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (New York Stock Exchange)
  • • Experienced leadership under James E. Davis
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.